Authors : Amato O, Aftimos P, Ignatiadis M Year : 2023 Journal : Ann Oncol
How I treat endocrine-dependent metastatic breast cancer.
Authors : Gombos A, Goncalves A, Curigliano G, Bartsch R, Kyte JA, Ignatiadis M, Awada A Year : 2023 Journal : ESMO Open
Reply to S. Di Cosimo et al.
Authors : Agostinetto E, Venet D, Ignatiadis M, Kalashnikova E Year : 2023 Journal : JCO Precis Oncol
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse.
Authors : Cailleux F, Agostinetto E, Lambertini M, Rothé F, Wu HT, Balcioglu M, Kalashnikova E, Vincent D, Viglietti G, Gombos A, Papagiannis A, Veys I, Awada A, Sethi H, Aleshin A, Larsimont D, Sotiriou C, Venet D, Ignatiadis M Year : 2022 Journal : JCO Precis Oncol
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast.
Authors : Agostinetto E, Nader-Marta G, Paesmans M, Ameye L, Veys I, Buisseret L, Neven P, Taylor D, Fontaine C, Duhoux FP, Canon JL, Denys H, Coussy F, Chakiba C, Ribeiro JM, Piccart M, Desmedt C, Ignatiadis M, Aftimos P Year : 2022 Journal : Future Oncol